TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›RBOT›Financials
Annual statements · SEC XBRL · FY2020 – FY2025

Vicarious Surgical Inc. (RBOT) financials

Income statement

Vicarious Surgical Inc. (RBOT) income statement, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating income-$13.0M-$38.2M-$80.1M-$80.7M-$66.6M-$50.0M
Net income-$12.9M-$35.2M$5.16M-$71.1M-$63.2M-$50.2M
EPS (diluted)-$0.16-$0.36$0.04-$0.49——

Cash flow

Vicarious Surgical Inc. (RBOT) cash flow, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$12.0M-$33.3M-$61.2M-$62.3M-$50.0M-$45.1M
Capital expenditures$120K$1.29M$5.35M$1.67M$180K$132K
Free cash flow-$12.2M-$34.6M-$66.6M-$64.0M-$50.1M-$45.2M

Balance sheet

Vicarious Surgical Inc. (RBOT) balance sheet, annual, from SEC filings
Fiscal yearFY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$16.9M$174M$116M$52.8M$9.74M$2.57M
Total assets$17.8M$182M$140M$120M$67.7M$19.6M
Total liabilities$935K$98.6M$29.2M$21.9M$21.0M$9.74M
Long-term debt$3.50M$675K—$2.00M——
Shareholders' equity-$29.8M$83.1M$111M$98.0M$46.7M$9.84M
Retained earnings-$31.6M-$66.8M-$61.6M-$133M-$196M-$246M
Shares (wtd avg diluted)78.7M96.7M128M4.87M5.89M6.13M

Every figure is extracted from Vicarious Surgical Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Vicarious Surgical Inc.'s free cash flow?
-$45.2M in FY2025 (operating cash flow -$45.1M minus $132K of capital expenditures), from the SEC cash-flow statement.
Does RBOT pay a dividend?
Vicarious Surgical Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full RBOT analysis — verdict, score & filings →Is RBOT a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.